Results 81 to 90 of about 12,775 (197)

Development and certification of an industrial reference standard for determination of filgrastim activity

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
The article provides with the information on certification of an industrial reference standard (IRS) for determination of filgrastim activity. In order to confirm the quality of the IRS candidate, the following tests have been performed: biological ...
E. V. Motuzova   +9 more
doaj  

Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United Kingdom [PDF]

open access: yes
Introduction: We report a cost-effectiveness evaluation of granulocyte colony–stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) after chemotherapy in the United Kingdom (UK).
Akehurst, R   +4 more
core  

A single prior course of BCNU-cisplatin chemotherapy has a significant deleterious effect on mobilization kinetics of otherwise untreated patients [PDF]

open access: yes, 2004
Extensive prior treatment with cytotoxic agents is associated with impaired mobilization of hematopoietic cells. To assess the effect of a single course of standarddose chemotherapy (CT), we compared the results of filgrastim-induced mobilization ...
Aramendia, J.M. (J.M.)   +8 more
core   +1 more source

Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA‐VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia

open access: yesBritish Journal of Haematology, Volume 208, Issue 2, Page 570-578, February 2026.
Summary Induction chemotherapy in fit de novo acute myeloid leukaemia (AML) patients has historically combined an anthracycline with standard‐dose cytarabine (‘7 + 3’) despite complete response (CR) rates of 50%–70%. In May 2023, our institution adopted the utilization of cladribine, cytarabine, idarubicin and venetoclax (CLIA‐VEN) for intensive ...
Benjamin J. Lee   +11 more
wiley   +1 more source

El AMD3100 (plerixafor) puede mejorar la movilización de células hematopoyéticaspara hacer trasplantes autólogos : Informe de un caso. [PDF]

open access: yes, 2009
La quimioterapia a dosis alta rescatada con trasplante de células hematopoyéticas autólogas se ha convertido en el tratamiento de elección en los pacientes con mieloma múltiple menores de 65 años de edad.
Hernández Arizpe, Ana   +5 more
core  

Biosimilars in the management of neutropenia: focus on filgrastim

open access: yesBiologics: Targets & Therapy, 2016
Désirée Caselli,1 Simone Cesaro,2 Maurizio Aricò1 1Medical Department, Pediatric Unit, Azienda Sanitaria Provinciale Ragusa, Ragusa, 2Department of Pediatrics, Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria ...
Caselli D, Cesaro S, Aricò M
doaj  

Pancytopenia following rituximab therapy in a patient with rheumatoid arthritis: Could filgrastim be a temporary solution?

open access: yesAsian Journal of Medical Sciences, 2016
Rheumatoid arthritis is a chronic inflammatory disease affecting the peripheral joints and can also have extraarticular manifestations.
Robin George Manappallil
doaj   +1 more source

PENGARUH MELOXICAM TERHADAP JUMLAH SEL DARAH TEPI TIKUS WISTAR YANG DIBERIKAN CYCLOPHOSPHAMIDE [PDF]

open access: yes, 2012
Latar belakang : Cyclophosphamide dapat mensupresi jumlah sel darah tepi akibat kematian sel-sel hematopoietik disertai hambatan terhadap stimulator hematopoietik.
Indriatmoko, Dika Patria
core  

Quantification of the cellular content of platelet-rich plasma harvested after injection of filgrastim versus pegfilgrastim biosimilars: a prospective, single-center, crossover study

open access: yesJournal of Cartilage & Joint Preservation
Introduction: Hematopoietic stem cells (HSCs) appear in peripheral blood (PB) following mobilization due to external events or pharmaceutical agents like filgrastim and pegfilgrastim.
Mohammadreza Abbasian   +6 more
doaj   +1 more source

Toxic epidermal necrolysis in hemodialysis patient

open access: yesAdvanced Biomedical Research, 2015
Toxic epidermal necrolysis (TEN) is a rare and life-threatening allergic drug reaction. We report a 26-year-old young female with end-stage renal disease on maintenance hemodialysis developing TEN while on filgrastim and phenytoin.
Uday Venkat Mateti   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy